TD 17.11 (iPOST)
Title: Phase III trial of postoperative radiotherapy with or without REGN2810 in high risk cutaneous squamous cell carcinoma of the head and neck (cSCCHN).
Primary Sponsor: Trans Tasman Radiation Oncology Group (TROG)
Trial development status: This investigator initiated study was approved for development on December 2018 by the TROG Scientific Committee.
|Case report forms and database
Approximate date of trial activation: 2019
Prof Danny Rischin, Peter MacCallum Cancer Centre
Prof Sandro Porceddu, Princess Alexandra Hospital
BaCT, Peter MacCallum Cancer Centre
Clinical trial registration: Coming soon
2018 ASM18 Presentation
EoI Template - NB: this is provided as a tool to aid completing the electronic survey
EOI Survey (Password: TROG)